News

Back

Univercells raises € 44 million in first close of its Series D

October 19th 2022

BSCB Dev

Univercells, a global life science company providing all-round solutions for biologics manufacturing, has raised € 44 million through the first close of its Series D financing round. In addition to the support of existing private and public shareholders, Univercells is very pleased to welcome prominent new investors from Belgium and the United States

Read Pdf